[Cellular senescence and pulmonary disease: COPD as an example].
L Boyer1, L Savale2, J Boczkowski3
1Service de physiologie-explorations fonctionnelles, DHU A-TVB, hôpital Henri-Mondor, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France; Inserm U955, faculté de médecine, 94010 Créteil, France; Université Paris-Est, UMR S955, faculté de médecine, 94010 Créteil, France.
Revue Des Maladies Respiratoires
|December 16, 2014
Summary
Cellular senescence, a key aging mechanism, may drive chronic lung diseases like COPD. This research explores senescence
Area of Science:
- Gerontology and Respiratory Medicine
- Cellular Biology and Disease Mechanisms
Background:
- Cellular senescence is a fundamental aging process with growing research interest.
- It is implicated as a potential driver of various age-related diseases, including chronic lung conditions like COPD and idiopathic pulmonary fibrosis.
- Premature lung cell senescence is hypothesized to contribute to the pathophysiology of respiratory alterations in these diseases.
Purpose of the Study:
- To review the role of cellular senescence in the pathophysiology of COPD.
- To examine the connection between pulmonary and systemic manifestations in COPD patients.
- To explore whether these manifestations suggest a generalized accelerated aging process.
Main Methods:
- Literature review focusing on cellular senescence and COPD.
- Analysis of existing arguments and evidence linking senescence to lung destruction, vascular remodeling, and inflammation.
- Investigation of studies on systemic manifestations (e.g., bone loss, muscle wasting, atherosclerosis) in COPD patients.
Main Results:
- Cellular senescence plays a role in lung destruction, vascular remodeling, and inflammation in COPD.
- Systemic manifestations in COPD patients, such as bone loss and muscle wasting, may be linked to pulmonary pathology.
- These findings suggest a potential common pathogenic mechanism or a general accelerated aging process in COPD.
Conclusions:
- Cellular senescence is a significant factor in COPD pathophysiology, affecting both lung and systemic health.
- The link between pulmonary and systemic symptoms in COPD may reflect an accelerated aging phenotype.
- Further research is needed to elucidate the precise mechanisms and therapeutic implications of cellular senescence in COPD.
Keywords:
AgingBPCOCOPDManifestations systémiquesSystemic manifestationsTelomereTélomèresVieillissementMore Related Videos
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.7K
09:07Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
Published on: July 12, 2024
2.0K
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.3K
01:23Chronic Obstructive Pulmonary Disease I: Introduction
3
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
3
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.3K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.3K
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
21
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
21
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
16
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
16